AI-powered market entry platform for pharma, biotech, and medtech teams, across 90+ markets including all 50 US states.
90 markets. 50 US states and 40+ international. The same framework that maps Texas Medicaid maps Vietnam or Saudi Arabia.
Here's what that looks like.
Regulatory approval, procurement, pricing, and funding, across 90 markets.
Real-time shifts across global health markets and what they mean for your product.
› Vietnam: Enter via Ministry of Health tender pathway. Biosimilar pricing window open Q3 2025. Recommended.
WHO PQ held products qualify for DAV expedited review via reliance pathway, compressing registration to 6–9 months. The Ministry of Health has identified insulin access as a national priority. Public procurement through hospital tenders accounts for 60% of volume.
Used by market access and BD teams at biotech, specialty pharma, and medtech companies evaluating international expansion.
Approval complexity, reliance pathway availability, and authority requirements calibrated to your existing clearances: CE Mark, 510(k), TGA, or WHO PQ.
Realistic months from submission to commercial clearance, including known authority bottlenecks and distributor onboarding lead times.
Public vs. private purchasing split, tender cycle cadence, and donor channel relevance: UNICEF, Gavi, Global Fund, and USAID.
Whether MoH sets reference or ceiling prices, reimbursement linkage signals, and commercial pricing flexibility in each channel.
Whether a local entity or distributor is legally required, entity type rules, and onboarding lead time for commercial operations.
Import duty rates, VAT/GST, medical device exemptions, and landed cost impact on margin and competitive pricing.
Enter your product type and existing clearances. Vantro ranks your top 5 markets by ease of entry: regulatory readiness, market size, and time to first sale.
Your top 5 markets will appear here
Market entry decisions used to cost $20,000 to $40,000 per market and take months. Vantro gives your team the same structured intelligence in minutes, cited to primary sources, calibrated to your product.
Tell us about your product and where you're headed.
Start free. Upgrade when you're ready.
All market briefs are cited to primary sources including WHO, World Bank, national regulatory authorities, and UNICEF Supply Division.